FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
16.5 |
IU/g |
1.71 |
5.13 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48896 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
18.41 |
IU/g |
2.25 |
6.38 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48901 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
13.64 |
IU/g |
2.07 |
5.85 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45997 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
0.31 |
IU/g |
0.03 |
0.08 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47352 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.24 |
IU/g |
0.05 |
0.13 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47488 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
62.45 |
% |
4.48 |
13.45 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46082 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
|
4.08 |
ml/min/g |
0.37 |
0.98 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46219 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
11.57 |
IU/g |
1.63 |
4.9 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46002 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
4.11 |
ml/min/g |
0.41 |
1.16 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44734 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
40.76 |
% |
4.43 |
12.52 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47093 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
10.26 |
ml/min/g |
0.6 |
1.7 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46669 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
11.71 |
ml/min/g |
0.45 |
1.44 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46671 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
5.03 |
ml/min/g |
0.48 |
1.43 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44736 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
5.1 |
ml/min/g |
0.53 |
1.58 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46217 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
43.5 |
% |
3.5 |
10.51 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47095 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
7 |
|
0.33 |
IU/g |
0.03 |
0.08 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47357 |
461 |
FHH-Chr 4BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
7 |
|
0.15 |
IU/g |
0.03 |
0.07 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47493 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
51.77 |
% |
5.56 |
14.72 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46084 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
8.18 |
ml/min/g |
0.7 |
2.1 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46886 |
461 |
FHH-Chr 4BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
|
8.11 |
ml/min/g |
0.65 |
1.72 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46888 |
461 |